Prometheus Labs Gets $260M in Debt Financing

1/7/10

San Diego-based Prometheus Laboratories, which develops specialty pharmaceuticals and diagnostic tests, says today it has secured $260 million in financing that consists of a $210 million loan and a $50 million line of credit. The company says proceeds will be used to finance the acquisition of more therapeutic and diagnostic products, and to refinance existing indebtedness.

Bruce V. Bigelow is the editor of Xconomy San Diego. You can e-mail him at bbigelow@xconomy.com or call (619) 669-8788 Follow @

By posting a comment, you agree to our terms and conditions.